Sarepta Therapeutics
SRPT
#1627
Rank
ยฃ8.30 B
Marketcap
ยฃ86.94
Share price
-0.89%
Change (1 day)
30.93%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -ยฃ6.35

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ6.20. In 2022 the company made an earnings per share (EPS) of -ยฃ6.35 a decrease over its 2021 EPS that were of -ยฃ4.07.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ6.35-0.11%
2022-ยฃ6.3555.92%
2021-ยฃ4.07-27.16%
2020-ยฃ5.59-26.96%
2019-ยฃ7.6678.6%
2018-ยฃ4.29603.9%
2017-ยฃ0.61-85.9%
2016-ยฃ4.325.2%
2015-ยฃ4.1153.1%
2014-ยฃ2.68-0%
2013-ยฃ2.68-33.79%
2012-ยฃ4.057214.29%
2011-ยฃ0.05539-96.11%
2010-ยฃ1.4215.38%
2009-ยฃ1.23-23.53%
2008-ยฃ1.61-37.04%
2007-ยฃ2.56-0%
2006-ยฃ2.5645.95%
2005-ยฃ1.76-46.38%
2004-ยฃ3.2840.82%
2003-ยฃ2.33-57.02%
2002-ยฃ5.41-2.56%
2001-ยฃ5.55138.78%
2000-ยฃ2.33-20.97%
1999-ยฃ2.94-72.2%
1998-ยฃ10.59519.44%
1997-ยฃ1.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ3.47-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.69-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.45-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.99-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.25-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ6.84 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ4.17-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA